Partner With Us

In addition to our 21 global offices, we promote or co-promote our branded products through a network of reputable agents. This can be on an exclusive or non-exclusive basis.

Medochemie undertakes contract manufacturing for a limited number of partners. The process includes the technology transfer of the partners’ production formulation and analytical methods to our relevant manufacturing plant. It also involves regulatory support and advice, a step necessary to have our production site approved in the partners’ Marketing Authorisation.

Our brand new oral dosage form (tablets & capsules) EU GMP approved facility in Vietnam offers competitively priced contract manufacturing services for large scale partner products.

Additionally, as from the end of 2016, we will also be able to offer contract manufacturing services at our newest high capacity gels, creams, ointments, syrups and injectable cephalosporins (powder for injection/infusion) facilities. Both these facilities located in Vietnam are currently in their final construction phase and will also undergo an EU GMP inspection.

The Licensing Department, in cooperation with the Regulatory Affairs Department, are engaged in the out-licensing of Medochemie's product dossiers, which aim to establish new, strategic contractual partnerships with other pharmaceutical companies in a market.

Our customers include the largest multinational generic companies as well as numerous local companies. In recent years, Medochemie has licensed out several product dossiers to customers in Western Europe, Canada, Australia, New Zealand and South Africa, with our products already registered on behalf of customers in 29 countries.

We have an impressive track record of maintaining partnerships beyond the expiration of contractual obligations, which demonstrates our customers’ high satisfaction levels with our products and services as well as our competitive prices.